Drug Development in the New Era: A Global Perspective
4th International conference on phase 1 and early phase clinical trials
March 1-2, 2018 | Hyatt Regency Hong Kong, Tsim Sha Tsui, 18 Hanoi Road, Kowloon, Hong Kong
Dr. Tommy Cheung, MBBS, MRCP, FHKCP, FHKAM (Medicine), FRCP (Edin), Dip Clin Tox (HKPIC & HKCEM)
Deputy Medical Director (Clinical Pharmacology) of Phase 1 Clinical Trials Centre, The University of Hong Kong
Clinical Assistant Professor of Division of Clinical Pharmacology and Therapeutics, Department of Medicine, The University of Hong Kong, HKSAR, China
Dr. Tommy Cheung is the Clinical Assistant Professor in the Department of Medicine, The University of Hong Kong. He obtained his fellowship in Rheumatology in 2011 before he continued his training in Clinical Pharmacology and Therapeutics.
After joining the university in 2012, he was also appointed the Clinical Assistant Professor in the HKU Shenzhen Hospital and the Deputy Medical Director of the Phase 1 Clinical Trial Centre, which has been accredited by the China Food and Drug Administration in 2016.
He has been the Principal Investigator of many Phase 1 clinical trials involving healthy subjects conducted in the Phase 1 Clinical Trial Centre.
Day Two: How to Meet the CFDA Requirements for Phase 1 Clinical Trials